[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address Please contact the publisher to request reinstatement.
[Skip to Content Landing]
February 20, 2002

Do Patents Prevent Access to Drugs for HIV in Developing Countries?

Author Affiliations

Stephen J.LurieMD, PhDIndividualAuthor

JAMA. 2002;287(7):840-843. doi:10.1001/jama.287.7.839

To the Editor: Dr Attaran and Mr Gillespie-White1 attempt to show that patents are not a substantial barrier to antiretroviral treatment access in Africa today. But our experience with Médecins Sans Frontières (Doctors Without Borders) in Africa shows that such an analysis is meaningless if the drug combinations required for effective therapy in a particular context are not considered.